Abrocitinib Bests Placebo for Treatment of Atopic Dermatitis
Significantly greater reductions seen in signs and symptoms of moderate-to-severe atopic dermatitis at week 12 compared with placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.